192 related articles for article (PubMed ID: 29601894)
1. Susceptibility of paramyxoviruses and filoviruses to inhibition by 2'-monofluoro- and 2'-difluoro-4'-azidocytidine analogs.
Lo MK; Jordan PC; Stevens S; Tam Y; Deval J; Nichol ST; Spiropoulou CF
Antiviral Res; 2018 May; 153():101-113. PubMed ID: 29601894
[TBL] [Abstract][Full Text] [Related]
2. 4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.
Hotard AL; He B; Nichol ST; Spiropoulou CF; Lo MK
Antiviral Res; 2017 Aug; 144():147-152. PubMed ID: 28629988
[TBL] [Abstract][Full Text] [Related]
3. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
Warren TK; Wells J; Panchal RG; Stuthman KS; Garza NL; Van Tongeren SA; Dong L; Retterer CJ; Eaton BP; Pegoraro G; Honnold S; Bantia S; Kotian P; Chen X; Taubenheim BR; Welch LS; Minning DM; Babu YS; Sheridan WP; Bavari S
Nature; 2014 Apr; 508(7496):402-5. PubMed ID: 24590073
[TBL] [Abstract][Full Text] [Related]
4. Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
Radoshitzky SR; Warfield KL; Chi X; Dong L; Kota K; Bradfute SB; Gearhart JD; Retterer C; Kranzusch PJ; Misasi JN; Hogenbirk MA; Wahl-Jensen V; Volchkov VE; Cunningham JM; Jahrling PB; Aman MJ; Bavari S; Farzan M; Kuhn JH
J Virol; 2011 Sep; 85(17):8502-13. PubMed ID: 21697477
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
6. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.
Lo MK; Jordan R; Arvey A; Sudhamsu J; Shrivastava-Ranjan P; Hotard AL; Flint M; McMullan LK; Siegel D; Clarke MO; Mackman RL; Hui HC; Perron M; Ray AS; Cihlar T; Nichol ST; Spiropoulou CF
Sci Rep; 2017 Mar; 7():43395. PubMed ID: 28262699
[TBL] [Abstract][Full Text] [Related]
7. Current status of small molecule drug development for Ebola virus and other filoviruses.
Edwards MR; Basler CF
Curr Opin Virol; 2019 Apr; 35():42-56. PubMed ID: 31003196
[TBL] [Abstract][Full Text] [Related]
8. Drug targets in infections with Ebola and Marburg viruses.
Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
[TBL] [Abstract][Full Text] [Related]
9. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
10. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
[TBL] [Abstract][Full Text] [Related]
11. A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor.
Selaković Z; Opsenica D; Eaton B; Retterer C; Bavari S; Burnett JC; Solaja BA; Panchal RG
Viruses; 2012 Aug; 4(8):1279-88. PubMed ID: 23012625
[TBL] [Abstract][Full Text] [Related]
12. Flex-nucleoside analogues - Novel therapeutics against filoviruses.
Yates MK; Raje MR; Chatterjee P; Spiropoulou CF; Bavari S; Flint M; Soloveva V; Seley-Radtke KL
Bioorg Med Chem Lett; 2017 Jun; 27(12):2800-2802. PubMed ID: 28465098
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors.
Anantpadma M; Kouznetsova J; Wang H; Huang R; Kolokoltsov A; Guha R; Lindstrom AR; Shtanko O; Simeonov A; Maloney DJ; Maury W; LaCount DJ; Jadhav A; Davey RA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4471-81. PubMed ID: 27161622
[TBL] [Abstract][Full Text] [Related]
14. The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Maltseva T; Leveque VJ; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Kaiser AC; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 May; 52(9):2971-8. PubMed ID: 19341305
[TBL] [Abstract][Full Text] [Related]
15. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.
Panchal RG; Reid SP; Tran JP; Bergeron AA; Wells J; Kota KP; Aman J; Bavari S
Antiviral Res; 2012 Jan; 93(1):23-9. PubMed ID: 22027648
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
17. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.
Bossart KN; Mungall BA; Crameri G; Wang LF; Eaton BT; Broder CC
Virol J; 2005 Jul; 2():57. PubMed ID: 16026621
[TBL] [Abstract][Full Text] [Related]
19. Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
Dawes BE; Kalveram B; Ikegami T; Juelich T; Smith JK; Zhang L; Park A; Lee B; Komeno T; Furuta Y; Freiberg AN
Sci Rep; 2018 May; 8(1):7604. PubMed ID: 29765101
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo.
Warfield KL; Warren TK; Qiu X; Wells J; Mire CE; Geisbert JB; Stuthman KS; Garza NL; Van Tongeren SA; Shurtleff AC; Agans KN; Wong G; Callahan MV; Geisbert TW; Klose B; Ramstedt U; Treston AM
Antiviral Res; 2017 Feb; 138():22-31. PubMed ID: 27908828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
